Cargando…
Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2
Hepatocyte growth factor (HGF) is a potent epithelial mitogen whose actions are mediated through its receptor, the proto-oncogene c-Met. Two truncated variants of HGF known as NK1 and NK2 have been reported to be competitive inhibitors of HGF binding to c-Met, and to function as HGF antagonists (Lok...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2120823/ https://www.ncbi.nlm.nih.gov/pubmed/8636243 |
Ejemplares similares
-
Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis
por: Tsunemi, Sachi, et al.
Publicado: (2013) -
The Antitumor Effect of Heparin is not Mediated by Direct NK Cell Activation
por: Rossi, Gustavo R., et al.
Publicado: (2020) -
The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway
por: WANG, DONGDONG, et al.
Publicado: (2016) -
Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012) -
Carbohydrate-Based NK1R Antagonists with Broad-Spectrum
Anticancer Activity
por: Recio, Rocío, et al.
Publicado: (2021)